“…As shown previously, a sole substituent on position-2 did not lead to hypotensive compounds, whatever its nature, alkyl group, or halogen atom, 28,57 opposite to what was observed with imidazoline compounds and nonselective pyrrolidines. 32,33,35 In the first series, in which compounds 1− 11 bear a methyl group on position-5 of the pyrrolidinyl ring, addition of a second substituent on the phenyl ring had different influences on the hypotensive activity, according to its position. When it was placed in position-6, in position-5, or in position-4 of the phenyl ring (compounds 1−4), compounds were unable to decrease MBP, even after ic injection.…”